The Danish medtech firm has production facilities in China, meaning it will avoid a potential ban on medical equipment not made in the country, which is being put in place by some hospitals on governmental request.
Workers’ wages have gone up in Hungary, where the Danish medtech firm makes most of its products. Now, part of the production is moving to where the grass is greener – across the Atlantic in Costa Rica.
New Nordic sustainable packaging criteria will be included in a Danish procurement tender for public hospitals, although the ”economy” and ”’user-friendliness” criteria are both weighted as twice as important.
Increasing energy prices, wage inflation in Hungary, sky-high freight rates, and unchecked raw material expenses are costing Coloplast dearly. Now, the company’s head of global operations acknowledges he should have laid better plans.
Kristian Villumsen, CEO of Coloplast, has learned lessons about how to speed up the medtech company’s future innovation, after some challenging development years that are finally culminating in the launch of completely new product types.
Atos Medical, the Danish medtech firm’s latest acquisition, will be fully integrated within a couple of years, says Coloplast CEO Kristian Villumsen, noting that the next acquisition will probably be smaller in scale.